Biotech startups in South Korea
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| HITS | Seoul | Series B | $13.5M | 2026-09-28 |
| Galux | Dogokdong | Series B | $29.0M | 2026-02-09 |
| Apollon | Seoul | Series A | $3.7M | 2026-09-22 |
| Standigm | Seoul | Series D | $10.0M | 2021-06-30 |
| Celloid | Seongnam | Series A | $6.1M | 2026-03-12 |
| PharmCADD | Busan | Series B | $16.0M | 2021-04-19 |
| Deargen | Daejeon | Series B | $16.6M | 2022-02-24 |
| LN Robotics | Hanam | Series B | $14.5M | 2024-07-09 |
8 rows of the CSV in 5 of its 18 columns.
- The 340 biotech startups in South Korea have raised $1.6B in total.
- 23 of them closed their most recent round in the last 12 months, $188.9M combined.
- The largest of those rounds is Galux's $29.0M Series B, dated February 2026.
- The most recent is Trioar's $24.9M Series C on 22 October 2026.
- TIPS Program is an investor in 14 of them, more than any other fund.
- Health care is the most common other sector, with 282 companies (83%).
- 36% were founded in 2020 or later; the median founding year is 2019.
- The most common team size is 11 to 50 employees (56% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
16 of 340| Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| HITS | HITS develops artificial intelligence software for drug discovery and pharmaceutical research. | Artificial intelligence | Seoul | Series B | $13.5M | 2026-09-28 | $25.1M | Korea Investment Partners, Capstone Partners, Company K Partners +2 | 11 to 50 | 2020 |
| Apollon | Apollon develops noninvasive continuous glucose monitoring systems. | Artificial intelligence | Seoul | Series A | $3.7M | 2026-09-22 | $6.4M | TIPS Program, KB Investment, TheVentures +2 | 11 to 50 | 2021 |
| Celloid | Celloid supplies a 3D cell culture medium that supports quality-controlled long-term cultivation of organoids. | Biotech | Seongnam | Series A | $6.1M | 2026-03-12 | $7.9M | FuturePlay, POSTECH Holdings | 1 to 10 | 2021 |
| Galux | Galux designs molecules to discover new drugs for incurable and rare diseases. | Artificial intelligence | Dogokdong | Series B | $29.0M | 2026-02-09 | $36.3M | Dayli Partners | 11 to 50 | 2020 |
| Cure Stream | Cure Stream develops an autonomous artificial pancreas system that uses an AI algorithm to decide hormone injections. | Artificial intelligence | Daegu | Series A | $7.8M | 2025-05-14 | $7.8M | TIPS Program | 2019 | |
| LN Robotics | LN Robotics is a technology research firm that develops medical robots. | Biotech | Hanam | Series B | $14.5M | 2024-07-09 | $21.3M | TIPS Program, Bluepoint, Mirae Asset Venture Investment +2 | 11 to 50 | 2019 |
| Space Lintech | Space Lintech manufactures medications for use in satellites and space stations. | Biotech | Daejeon | Series A | $2.9M | 2024-04-11 | $2.9M | Company K Partners, Woori Venture Partners | 1 to 10 | 2021 |
| Surginex | Surginex develops biological drugs and offers molecular biology, genetics, and physical and chemical analysis services. | Biotech | Seocho | Series B | $6.3M | 2024-03-28 | Hana Ventures, Laguna Investment, Partners Investment +1 | 1 to 10 | 2020 | |
| Ultimate Potential | Ultimate Potential is a brand offering hyper-personalized sports nutrition. | Biotech | Seoul | Seed | $39K | 2023-12-26 | CNTTECH, Strong Ventures | 11 to 50 | 2020 | |
| Novorex | Novorex develops molecule drugs for oncology and neurology diseases. | Biotech | Seongnam | Series A | $8.9M | 2023-11-21 | $8.9M | TIPS Program, KB Investment, Hana Ventures +2 | 1 to 10 | 2020 |
| Plcoskin | Plcoskin is a MedTech company that offers reconstructive plastic surgery and regenerative skincare. | Biotech | Seoul | Series B | $4.5M | 2023-08-31 | TIPS Program, Primer, We Ventures +1 | 11 to 50 | 2018 | |
| Deargen | Deargen provides AI-based genome analysis services. | Artificial intelligence | Daejeon | Series B | $16.6M | 2022-02-24 | TIPS Program, Hana Ventures, The Wells Investment | 51 to 100 | 2016 | |
| NetTargets | NetTargets provides AI-focused drug discovery research services. | Artificial intelligence | Yusong | Series A | $5.3M | 2021-07-02 | TIPS Program, Bluepoint, WE Ventures +2 | 11 to 50 | 2019 | |
| PharmCADD | PharmCADD uses AI protein structure prediction, molecular dynamics, and quantum calculations to speed drug design. | Artificial intelligence | Busan | Series B | $16.0M | 2021-04-19 | DSC Investment, KB Securities, KDB Capital +1 | 51 to 100 | 2019 | |
| Biobab AiBIO | Biobab AiBIO is a biotechnology company developing drugs using artificial intelligence. | Artificial intelligence | Incheon | Series A | $14.1M | 2021-03-15 | $14.1M | Mirae Asset Venture Investment, Aju IB Investment, Mirae Asset Capital +2 | 11 to 50 | 2018 |
| Looxid Labs | Looxid Labs integrates emotion recognition with virtual reality using eye and brain interface technology. | Artificial intelligence | Seoul | Series A | $4.0M | 2018-11-12 | TIPS Program, Samsung Ventures, Bluepoint +2 | 1 to 10 | 2015 |
Table 1. Biotech startups in South Korea: the 16 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 340.
Largest rounds
Last 12 months| # | Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Galux | Galux designs molecules to discover new drugs for incurable and rare diseases. | Artificial intelligence | Dogokdong | Series B | $29.0M | 2026-02-09 | $36.3M | Dayli Partners | 11 to 50 | 2020 |
| 2 | HITS | HITS develops artificial intelligence software for drug discovery and pharmaceutical research. | Artificial intelligence | Seoul | Series B | $13.5M | 2026-09-28 | $25.1M | Korea Investment Partners, Capstone Partners, Company K Partners +2 | 11 to 50 | 2020 |
| 3 | Celloid | Celloid supplies a 3D cell culture medium that supports quality-controlled long-term cultivation of organoids. | Biotech | Seongnam | Series A | $6.1M | 2026-03-12 | $7.9M | FuturePlay, POSTECH Holdings | 1 to 10 | 2021 |
| 4 | Apollon | Apollon develops noninvasive continuous glucose monitoring systems. | Artificial intelligence | Seoul | Series A | $3.7M | 2026-09-22 | $6.4M | TIPS Program, KB Investment, TheVentures +2 | 11 to 50 | 2021 |
Table 2. Biotech startups in South Korea: the 4 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | TIPS Program | Startup incubator | Gangneung, South Korea | 14 | 4% | 1 | Apollon |
| 2 | Company K Partners | Venture capital firm | Ilsangu, South Korea | 4 | 1% | 1 | HITS |
| 3 | KB Investment | Private equity firm | Seoul, South Korea | 4 | 1% | 1 | Apollon |
| 4 | Mirae Asset Venture Investment | Venture capital firm | Seongnam, South Korea | 4 | 1% | ||
| 5 | Bluepoint | Startup accelerator | Daejeon, South Korea | 4 | 1% | ||
| 6 | STIC Ventures | Venture capital firm | Seoul, South Korea | 3 | 1% | 2 | HITS, Apollon |
| 7 | Hana Ventures | Corporate venture arm | Seoul, South Korea | 3 | 1% | ||
| 8 | Mirae Asset Capital | Investment bank | Seoul, South Korea | 3 | 1% | ||
| 9 | UTC Investment Co. | Venture capital firm | Seoul, South Korea | 3 | 1% | ||
| 10 | Kiwoom Investment | Venture capital firm | Youidodong, South Korea | 2 | 1% | 1 | HITS |
| 11 | Korea Investment Partners | Private equity firm | Seoul, South Korea | 2 | 1% | 1 | HITS |
| 12 | TheVentures | Venture capital firm | Seoul, South Korea | 2 | 1% | 1 | Apollon |
| 13 | Future Science and Technology Holdings | Venture capital firm | Daejeon, South Korea | 2 | 1% | 1 | Apollon |
| 14 | Kolon Investment | Private equity firm | Seoul, South Korea | 2 | 1% | ||
| 15 | Woori Venture Partners | Private equity firm | Seongnam, South Korea | 2 | 1% |
Table 3. Biotech startups in South Korea: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 282 | 83% | $1.4B |
| Software | 32 | 9% | $132.6M |
| Artificial intelligence | 23 | 7% | $97.5M |
| Hardware | 19 | 6% | $54.2M |
| Cybersecurity | 3 | 1% | |
| Education | 1 | 0% | |
| Commerce | 1 | 0% | |
| Fintech | 1 | 0% | |
| Energy | 1 | 0% |
Table 4. Biotech startups in South Korea by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
Table 5. Biotech startups in South Korea by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Cities
Table 6. Biotech startups in South Korea by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| November 2026 | 1 | 4% | |
| October 2026 | 2 | 9% | $24.9M |
| September 2026 | 5 | 22% | $39.3M |
| August 2026 | 2 | 9% | $8.8M |
| July 2026 | 1 | 4% | $6.7M |
| June 2026 | 2 | 9% | $14.0M |
| April 2026 | 1 | 4% | |
| March 2026 | 4 | 17% | $53.4M |
| February 2026 | 2 | 9% | $30.5M |
| December 2025 | 3 | 13% | $11.3M |
Table 7. Biotech startups in South Korea: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 20 | 6% | $177.6M |
| 2025 | 23 | 7% | $150.2M |
| 2024 | 35 | 10% | $191.6M |
| 2023 | 53 | 16% | $183.7M |
| 2022 | 71 | 21% | $465.1M |
| 2021 | 71 | 21% | $923.3M |
Table 8. Biotech startups in South Korea by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 16 | 5% |
| 2020 to 2022 | 102 | 31% |
| 2015 to 2019 | 173 | 52% |
| 2010 to 2014 | 24 | 7% |
| Before 2010 | 15 | 5% |
Table 9. Biotech startups in South Korea by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 84 | 33% |
| 11 to 50 | 142 | 56% |
| 51 to 100 | 24 | 9% |
| 101 to 250 | 3 | 1% |
| 501 to 1,000 | 2 | 1% |
Table 10. Biotech startups in South Korea by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its headquarters is in South Korea. On 16 November 2026 that is 340 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 16 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 340 rows: 107 have no round amount, 0 no city and 125 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in South Korea are on the list?
- 340, in the file dated 16 November 2026. 23 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 340 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.